Ikena Oncology Competitors and Similar CompaniesClear all

Ikena Oncology's competitors and similar companies include Antikor, iBio, Century Therapeutics and EpiPharm.

	Ikena Oncology Ikena Oncology (formerly Kyn Therapeutics) is a biotechnology company that discovers and develops biomarker-driven therapies for cancer treatment.	Antikor Antikor is a biotechnology company that specializes in the discovery and development of small-format antibody-drug conjugates.	iBio iBio is a biotechnology research company.	Century Therapeutics Century Therapeutics is a biotech company that develops therapies to treat cancer.	EpiPharm EpiPharm is a biopharmaceutical company developing non-invasive products for the treatment of benign skin tumours and hyperpigmentation disorders.
Founding Date	Founding Date 2016	Founding Date 2014	Founding Date 2008	Founding Date 2018	Founding Date 2007
Type	Type Public	Type Private	Type Public	Type Public	Type Private
Tags	Tags Healthcare biotech oncology pharma therapy	Tags Healthcare biotech oncology pharma therapy	Tags Healthcare biotech oncology pharma therapy	Tags Healthcare biotech oncology pharma therapy	Tags Healthcare biotech oncology pharma therapy
Locations	Locations Boston, US HQ	Locations Stevenage, GB HQ	Locations San Diego, US HQ Bryan, US	Locations Philadelphia, US HQ Hamilton, CA Seattle, US	Locations Binningen, CH HQ
Employees	Employees 5052% increase	Employees 11	Employees 1630% decrease	Employees 107	Employees 4
Valuation ($)	Valuation ($) 82.5 m	Valuation ($) N/A	Valuation ($) 26.2 m	Valuation ($) 115.2 m	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) $800k (FY, 2025)	Revenue (est.) N/A	Revenue (est.) $400k (FY, 2025)	Revenue (est.) $109.2m (FY, 2025)	Revenue (est.) N/A
Net income	Net income ($45.3m) (FY, 2025)	Net income N/A	Net income N/A	Net income ($9.6m) (FY, 2025)	Net income N/A
Funding
Total funding raised	Total funding raised $ 49m	Total funding raised N/A	Total funding raised $ 9.3m	Total funding raised $ 410m	Total funding raised N/A